Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-081739·Elicio Therapeutics, Inc.
Schedule 13D ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2025-06-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- GKCC, LLCReported CIK 0001977769
Shares: 9,752,139 · Class: 48%
- Yekaterina ChudnovskyReported CIK 0001979324
Shares: 9,764,864 · Class: 48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-081739
- Form type
- SCHEDULE 13D/A
- Filer
- Elicio Therapeutics, Inc.
- CIK
- CIK 1601485
- Filed
- Jun 04, 2025
- Reporting period
- Jun 03, 2025
- Description
- Schedule 13D beneficial ownership